|
Market Closed -
Nasdaq
07:00:00 30/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 6.640 USD | +9.21% |
|
+3.91% | +58.85% |
| 21/09 | Precigen Receives Fda Platform Technology Designation for Adenoverse Platform | CI |
| 21/09 | Precigen's AdenoVerse Receives FDA Platform Technology Designation | MT |
| Market Cap | 2.38B 2.13B 1.96B 1.78B 3.32B 226B 3.38B 23.44B 9.35B 118B 8.92B 8.73B 375B | P/E 2026 * |
30.9x | P/E 2027 * | 10.7x |
|---|---|---|---|---|---|
| Enterprise Value | 2.38B 2.13B 1.96B 1.78B 3.32B 226B 3.38B 23.44B 9.35B 118B 8.92B 8.73B 375B | EV / Sales 2026 * |
10.1x | EV / Sales 2027 * | 5.44x |
| Free-Float |
87.36% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PGEN | Delayed | |
CBOE
| PGEN | Real-time | |
|
Tradegate
| I5X | Real-time | |
|
Berne S.E.
| I5X | End-of-day quote | |
|
Boerse Muenchen
| I5X | Real-time | |
|
Deutsche Boerse AG
| I5X | Delayed | |
|
Börse Stuttgart
| I5X | Delayed |
Last Transcript: Precigen, Inc.
| 1 day | +9.21% | ||
| 1 week | +3.91% | ||
| Current month | -22.43% | ||
| 1 month | -17.52% | ||
| 3 months | +21.83% | ||
| 6 months | +61.17% | ||
| Current year | +58.85% |
| 1 week | 5.96 |  | 6.98 |
| 1 month | 5.96 | | 8.64 |
| Current year | 3.04 | | 8.98 |
| 1 year | 3.04 | | 8.98 |
| 3 years | 0.65 | | 8.98 |
| 5 years | 0.65 | | 8.98 |
| 10 years | 0.65 | | 32.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Sabzevari
CEO | Chief Executive Officer | 64 | 01/01/2020 |
Harry Thomasian
DFI | Director of Finance/CFO | 64 | 01/10/2021 |
Amy Lankford
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Randal Kirk
CHM | Chairman | 72 | 01/02/2008 |
Cesar Alvarez
BRD | Director/Board Member | 78 | 01/02/2008 |
Jeffrey Kindler
BRD | Director/Board Member | 70 | 28/11/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 23/9/26 | Exercice | Chief Financial Officer | 107,330 | 0.0360% | ||
| 26/8/26 | Sell | Director | -185,000 | 0.0620% | ||
| 25/8/26 | Exercice | Executive/Senior Manager | 237,498 | 0.0796% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.21% | +3.91% | +65.59% | +557.43% | 2.38B | |
| +6.63% | +5.13% | +68.86% | +145.20% | 1,224B | |
| +1.53% | +2.84% | +47.48% | +89.01% | 662B | |
| +1.68% | +1.96% | +29.16% | +109.31% | 514B | |
| +0.73% | +2.45% | +54.26% | +68.96% | 388B | |
| +3.83% | -0.62% | +69.01% | +42.32% | 361B | |
| +2.38% | +2.65% | +34.31% | +57.95% | 302B | |
| +2.26% | +0.55% | +3.92% | +28.92% | 271B | |
| +1.97% | +3.01% | +57.91% | +76.14% | 249B | |
| +4.03% | +5.36% | +39.76% | +116.14% | 205B | |
| Average | +3.03% | +2.72% | +47.03% | +129.14% | 417.92B | |
| Weighted average by Cap. | +2.26% | +3.04% | +50.45% | +96.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 236M 211M 195M 176M 330M 22.46B 335M 2.32B 928M 11.75B 885M 866M 37.22B | 437M 391M 361M 327M 611M 41.62B 621M 4.31B 1.72B 21.78B 1.64B 1.61B 68.99B |
| Net income | 83.46M 74.76M 68.97M 62.41M 117M 7.95B 119M 823M 328M 4.16B 313M 307M 13.17B | 240M 215M 198M 179M 335M 22.84B 341M 2.36B 943M 11.95B 900M 881M 37.86B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | USD 6.640 | +9.21% | 7,742,783 |
| 28/10/26 | USD 6.080 | -1.14% | 3,673,952 |
| 27/10/26 | USD 6.150 | +1.82% | 3,790,136 |
| 26/10/26 | USD 6.040 | -2.42% | 2,547,296 |
| 23/10/26 | USD 6.190 | -3.13% | 4,347,284 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PGEN Stock
Select your edition
All financial news and data tailored to specific country editions
